- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Haruhiko Fukuda
Total 160 results
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompleted
-
University of PaviaHelp for optimism NGO; Kukula ONLUS; Elpis Nave Ospedale ONLUSCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedLiver Tumor | Evidence of Liver TransplantationChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedTongue CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Esophageal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedSecondary Malignant Neoplasm of LiverChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Liver CarcinomaChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedNon-small Cell Lung Cancer MetastaticChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Pharyngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Adult Soft Tissue SarcomaChina
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedPancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Renal Cell CancerChina
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Tongue CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Breast CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedPancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Non-small Cell Lung CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Laryngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedNon-small Cell Lung Cancer MetastaticChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Cervical CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedBreast Cancer RecurrentChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Nasopharyngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Colorectal CancerChina
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney CancerAdvanced Kidney CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Lung CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Pancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Liver CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Colorectal CancerChina
-
Fuda Cancer Hospital, GuangzhouShanghai Asclepius Meditech Co., LtdCompleted
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Gastric CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast CancerAdvanced Breast CancerChina
-
Mansoura University HospitalAzza Tarik Eliwa; Ahmed Elsayed Mansour; Taha Taha Abdelgawad; Ahmed Mohamed FoudaCompletedCOPD Exacerbation AcuteEgypt
-
Lithuanian University of Health SciencesKlaipėda University; Minneapolis Heart Institute; Kreiskrankenhaus Rotenburg...Recruiting
-
Fuda Cancer Hospital, GuangzhouGuangzhou Four-Leaf Clover HealthTech Co., Ltd.WithdrawnKnee Osteoarthritis | Stem Cell Transplant ComplicationsChina
-
Fuda Cancer Hospital, GuangzhouGuangzhou Four-Leaf Clover HealthTech Co., Ltd.WithdrawnPremature Ovarian Failure | Stem Cell Transplant ComplicationsChina
-
Kyushu UniversityNovartis; Kurume University; Fukuoka University; University of Occupational and... and other collaboratorsUnknownVisual Disorder Due to Age-related Macula DegenerationJapan
-
Fuda Cancer Hospital, GuangzhouGuangzhou Four-Leaf Clover HealthTech Co., Ltd.WithdrawnStem Cell Transplant Complications | Skin InflammationChina
-
Fuda Cancer Hospital, GuangzhouGuangzhou Four-Leaf Clover HealthTech Co., Ltd.Withdrawn
-
Lithuanian University of Health SciencesKlaipėda University; Kreiskrankenhaus Rotenburg an der fluda; Alkafeel Super...RecruitingCoronary Artery Disease | Stable AnginaLithuania